Fulgent Genetics names new chief medical officer
- BySeeking Alpha-
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Fulgent Genetics Inc (FLGT)
NASDAQ
Symbol | Exchange | Currency |
|---|
73.95
-6.73(-8.34%)
Pre Market
73.17
-0.78(-1.05%)
- Real-time Data
- Volume:1,447,328
- Bid/Ask:73.00/77.77
- Day's Range:72.80 - 82.78
FLGT Overview
- Prev. Close
- 73.95
- Day's Range
- 72.8-82.78
- Revenue
- 773.4M
- Open
- 81
- 52 wk Range
- 15.3-189.88
- EPS
- 14.85
- Volume
- 1,447,328
- Market Cap
- 2.14B
- Dividend (Yield)
- N/A(N/A)
- Average Vol. (3m)
- 1,129,953
- P/E Ratio
- 4.98
- Beta
- 1.51
- 1-Year Change
- 364.22%
- Shares Outstanding
- 29,005,206
- Next Earnings Date
- Aug 09, 2021
What is your sentiment on Fulgent Genetics Inc?
or
Market is currently closed. Voting is open during market hours.
Fulgent Genetics Inc News
- Fulgent Genetics Q1 2021 Earnings Preview
- BySeeking Alpha-
- Oppenheimer Stick to Their Buy Rating for Fulgent Genetics Inc
- ByInvesting.com-
Oppenheimer analyst Kevin DeGeeter maintained a Buy rating on Fulgent Genetics (NASDAQ:FLGT) Inc on Tuesday, setting a price target of $126, which is approximately 30.43% above the...
Fulgent Genetics Inc Analysis
- Fulgent Genetics: Get In Early Before It Starts To Take Off
- BySeeking Alpha-
- 2 Small-Cap ETFs For Growth Portfolios
Small-cap stocks can boost portfolio diversification and increase potential returns over time. While the definition of small-caps may vary slightly across US brokerages, it is...
- Fulgent Genetics: The Good And The Bad Discussed
- BySeeking Alpha-
Technical Summary
Type | 5 Min | 15 Min | Hourly | Daily | Monthly |
|---|---|---|---|---|---|
| Moving Averages | Neutral | Sell | Strong Sell | Strong Sell | Buy |
| Technical Indicators | Buy | Strong Sell | Strong Sell | Sell | Strong Buy |
| Summary | Neutral | Strong Sell | Strong Sell | Strong Sell | Strong Buy |
Trending Stocks
Trending Stocks
Name | Last | High | Low | Chg. | Chg. % | Vol. | Time | ||
|---|---|---|---|---|---|---|---|---|---|
| 2,430.20 | 2,441.72 | 2,418.96 | -4.93 | -0.20% | 1.10M | NASDAQ | |||
| 331.26 | 332.83 | 328.93 | -1.20 | -0.36% | 13.59M | NASDAQ | |||
| 233.34 | 241.13 | 206.13 | +12.95 | +5.88% | 15.58M | NYSE | |||
| 49.40 | 49.60 | 42.01 | +6.59 | +15.39% | 218.01M | NYSE | |||
| 187.69 | 190.95 | 186.67 | -2.52 | -1.32% | 3.29M | NASDAQ | |||
| 17.20 | 17.55 | 16.97 | -0.09 | -0.52% | 5.73M | NASDAQ | |||
| 9.75 | 10.77 | 9.34 | -0.93 | -8.71% | 577.94K | NASDAQ | |||
| 211.31 | 211.34 | 209.95 | -0.34 | -0.16% | 132.57K | NYSE | |||
| 211.64 | 213.46 | 211.00 | -1.43 | -0.67% | 12.28M | NYSE | |||
| 30.08 | 30.20 | 29.85 | +0.11 | +0.37% | 11.42M | NYSE | |||
| 14.18 | 14.33 | 13.57 | +0.29 | +2.09% | 56.13M | NYSE | |||
| 24.67 | 24.71 | 24.03 | +0.53 | +2.20% | 33.11M | NYSE | |||
| 118.25 | 118.42 | 117.16 | +0.01 | +0.01% | 6.04M | NYSE | |||
| 45.68 | 46.26 | 42.76 | +2.92 | +6.83% | 85.73M | NYSE | |||
| 1.61 | 1.65 | 1.61 | -0.020 | -1.21% | 38.60K | OTC Markets |
Fulgent Genetics Inc Company Profile
Fulgent Genetics Inc Company Profile
Fulgent Genetics, Inc. is a technology company. The Company offers genetic testing to provide physicians with clinically actionable diagnostic information to improve quality of patient care. The Company has developed a technology platform that integrates data comparison and suppression algorithms, adaptive learning software, advanced genetic diagnostics tools and integrated laboratory processes. As of December 31, 2015, the Company's test menu includes approximately 18,000 single-gene tests and over 200 pre-established, multi-gene, disease-specific panels that collectively test for approximately 7,500 genetic conditions, including various cancers, cardiovascular diseases and neurological disorders. The Company's gene probes are specifically engineered to generate genetic data that is optimized for its software, which enables to rapidly incorporate new genes into its test menu, develop new panels of disease-specific tests and customize tests for its customers.
Read More
- 2021-05-28 22:37:30
FLGT's short interest is 32,89%. Why is so high? Isn't it worrisome? - 2021-05-06 21:46:21
I see ...... light, in the background- 2021-05-07 10:20:34
only +5% premarket.. hope to see more upward movement when the market is open.. - 2021-05-07 10:40:42yes , I believe , because I think that drop is ends.. the US-TECH 100 yesterday make rotation. and today show good.I hope the situation is as it seems.
- 2021-05-05 22:23:21I see big companies have profits the Q1 and to falling 20% .. and I'm scared for tomorrow.
- 2021-05-06 13:29:42Let's just hope for the best. I myself now am at -21%.. lol
- 2021-05-06 13:34:11-30%
- 2021-05-06 14:58:49
ELLIN Raul Pablo Jiackoni Same
- 2021-04-29 20:25:04I think the stock will jump after earnings. Should get close to 100 I hope
- 2021-04-30 05:05:08I hope we will see an EPS of 10 or something..
- 2021-04-29 15:37:56Wow, can this get any lower?
- 2021-04-13 09:57:04
what's going with this stock it keeps going down..should I sell or hold I'm in at 110- 2021-04-13 11:53:47I have the same exact question..
- 2021-04-29 19:17:04
I'll hold, it's too late to sold
- 2021-03-10 03:00:41Dont gamble, research what the does before investing. The story behind this one is just begining.
- 2021-03-06 22:37:40
this one is good stock - 2021-03-06 22:37:21hey
- 2021-02-01 16:43:10what is this....
- 2021-01-27 18:37:00
Alpha Pro Tech, Ltd. (APT), made face mask, up 16% - 2021-01-27 18:10:34Why this increase +16%? Any news or just a crazy good stock ?
- 2021-02-09 11:22:05Crazy good stock it is. Another is APPS - Digital Turbine.
- 2021-01-19 16:58:24
As the company currently stands it is value somewhere at $120/share. We’ll see 🤷♂️ - 2021-01-12 08:11:48
Consolidation hjere is confirmation of a bull flag, as long as we dont dip below $58 - 2021-01-08 15:13:55Whats going on????
- 2021-01-08 15:26:26Profit taking after a massive rally
- 2021-01-08 16:23:05it will continue growing, Covid is not even close to finish, easily can be over 100 usd
- 2021-01-08 22:09:41Credit suisse downgraded the stock today from Neutral to underperform. Seems to be what drove some of the selling today
- 2021-01-08 04:46:23Good business model.
- 2021-01-03 23:46:51Clint, Areas I am lookin at tomorrow. https://invst.ly/tbtdc
- 2020-12-10 17:27:32🚀🚀🚀🚀
- 2020-12-09 15:25:15SkyRocketing!!!
- 2020-08-27 13:47:10What is wrong??? is anyone know what is going on
- 2020-08-27 15:08:23been following this for weeks...idfk
- 2020-11-13 16:35:49Its begining to believe.
- 2020-08-13 17:39:57Fulgent still *******it...anyone have any reasonable price targets?
- 2020-08-10 14:17:18Back again, hoping for another green close
- 2020-08-07 11:53:26Fulgent up to 38.54 in pre-market....this stock is just crazy
- 2020-08-06 04:26:02Don't think there's any experts here Mike B .just us scratching our heads looking in the green
- 2020-08-06 11:52:07Great management. Looking long. Bullish.
- 2020-08-03 15:39:18back again, why is this stock crushing it???
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data. Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.